Australia markets closed

Encompass Health Corporation (EHC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
61.56-0.02 (-0.03%)
At close: 04:00PM EST
61.56 +0.04 (+0.07%)
After hours: 04:04PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 6.33B
Enterprise value 9.69B
Trailing P/E 15.66
Forward P/E 15.04
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.27
Price/book (mrq)3.43
Enterprise value/revenue 1.93
Enterprise value/EBITDA 8.94

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3-23.41%
S&P500 52-week change 317.11%
52-week high 389.68
52-week low 356.31
50-day moving average 363.07
200-day moving average 374.64

Share statistics

Avg vol (3-month) 3952.27k
Avg vol (10-day) 31.1M
Shares outstanding 599.49M
Implied shares outstanding 6N/A
Float 897.39M
% held by insiders 11.96%
% held by institutions 194.33%
Shares short (13 Jan 2022) 42.2M
Short ratio (13 Jan 2022) 42.46
Short % of float (13 Jan 2022) 42.90%
Short % of shares outstanding (13 Jan 2022) 42.21%
Shares short (prior month 14 Dec 2021) 42.02M

Dividends & splits

Forward annual dividend rate 41.12
Forward annual dividend yield 41.82%
Trailing annual dividend rate 31.12
Trailing annual dividend yield 31.82%
5-year average dividend yield 41.69
Payout ratio 427.59%
Dividend date 317 Jan 2022
Ex-dividend date 430 Dec 2021
Last split factor 21:5
Last split date 325 Oct 2006

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 8.10%
Operating margin (ttm)16.33%

Management effectiveness

Return on assets (ttm)7.68%
Return on equity (ttm)24.32%

Income statement

Revenue (ttm)5.02B
Revenue per share (ttm)50.69
Quarterly revenue growth (yoy)9.40%
Gross profit (ttm)1.76B
EBITDA 1.07B
Net income avi to common (ttm)405.3M
Diluted EPS (ttm)4.06
Quarterly earnings growth (yoy)28.70%

Balance sheet

Total cash (mrq)94.8M
Total cash per share (mrq)0.95
Total debt (mrq)3.46B
Total debt/equity (mrq)150.73
Current ratio (mrq)1.15
Book value per share (mrq)18.52

Cash flow statement

Operating cash flow (ttm)871.7M
Levered free cash flow (ttm)194.21M